Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3926 results

Sort By:

A Phase III Trial of HRS-1893 in Patients With Obstructive Hypertrophic Cardiomyopathy

Study ID: NCT07021976
Start Date: 2025-08
End Date: 2026-11
Study Type

Interventional

Study Phase

Phase3

No. of Participants

216

Intervention / Treatment

HRS-1893 Tablets

HRS-1893 Placebo Tablets

Sponsor

Shandong Suncadia Medicine Co., Ltd.

Source: clinicaltrials.gov

Share:
Add to list

Grain Moxibustion Treatment on Insomnia: a Randomized Controlled Trial

Study ID: NCT04980703
Start Date: 2027-07-01
End Date: 2029-07-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

102

Intervention / Treatment

Grain moxibustion

Sham grain moxibustion

Standard care

Sponsor

Shanghai Institute of Acupuncture, Moxibustion and Meridian

Source: clinicaltrials.gov

Share:
Add to list

Mandibular Implant Overdenture With OT Cap Bar vs Bar Attachment: A Randomized Controlled Trial

Study ID: NCT07067190
Start Date: 2025-09
End Date: 2026-03
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

22

Intervention / Treatment

Conventional Bar Attachment

Bar with OT Cap Attachment

Sponsor

Maisa Mohamed Farid Shaaban

Source: clinicaltrials.gov

Share:
Add to list

Effects of Chemotherapy Treatment on Metaboreflex, Mechanoreflex, and Baroreflex Function: PROTECT-08B Study

Study ID: NCT07069790
Start Date: 2025-07-20
End Date: 2026-07-20
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

24

Intervention / Treatment

Test of neuromuscular fatigue and associated hemodynamic responses

Sponsor

Paul Strauss center

Source: clinicaltrials.gov

Share:
Add to list

Cupping Therapy in Chronic Nonspecific Low Back Pain

Study ID: NCT06193603
Start Date: 2025-10-01
End Date: 2026-12-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

48

Intervention / Treatment

True dry cupping therapy

Sham cupping therapy

Sponsor

Iran University of Medical Sciences

Source: clinicaltrials.gov

Share:
Add to list

Technology Assisted Motivational Interviewing

Study ID: NCT06713603
Start Date: 2025-08-15
End Date: 2027-05-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

440

Intervention / Treatment

TAMI Coach

Sponsor

University of California, San Francisco

Source: clinicaltrials.gov

Share:
Add to list

Promoting Neuroplastic Changes of Patients With TBI

Study ID: NCT06465290
Start Date: 2025-09
End Date: 2030-08-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

100

Intervention / Treatment

Motor relearning training with wearable ankle robot

Passive stretching with wearable ankle robot

Gamed-based active movement training with wearable ankle robot

Passive movement with limited wearable ankle robot

Active movement training with limited wearable ankle robot

Ankle torque and motion measurement with limited wearable ankle robot

Sponsor

University of Maryland, Baltimore

Source: clinicaltrials.gov

Share:
Add to list

Probiotic Supplementation During Cytotoxic Chemotherapy for Solid Tumor Malignancies

Study ID: NCT06772090
Start Date: 2025-12-25
End Date: 2027-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

40

Intervention / Treatment

Lactobacillus and Bifidobacterium

Placebo

Sponsor

Masonic Cancer Center, University of Minnesota

Source: clinicaltrials.gov

Share:
Add to list

Concurrent Trials on Nature-Based Therapy for Inpatients in Dementia and Rehabilitation Medicine Wards

Study ID: NCT07059390
Start Date: 2025-08
End Date: 2027-08
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

1600

Intervention / Treatment

Nature Immersion Therapy

Sponsor

Changi General Hospital

Source: clinicaltrials.gov

Share:
Add to list

A Study of Nemolizumab for the Treatment of Adults With Systemic Sclerosis

Study ID: NCT07047690
Start Date: 2025-08-29
End Date: 2027-10-29
Study Type

Interventional

Study Phase

Phase2

No. of Participants

162

Intervention / Treatment

Unmoisumab

Placebo

Sponsor

Galderma R&D

Source: clinicaltrials.gov

Share:
Add to list